Share-based Payment Arrangement, Expense in USD of Fresh Tracks Therapeutics, Inc. from 2010 to Q4 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Fresh Tracks Therapeutics, Inc. quarterly and annual Share-based Payment Arrangement, Expense history and change rate from 2010 to Q4 2023.
  • Fresh Tracks Therapeutics, Inc. Share-based Payment Arrangement, Expense for the quarter ending 31 Dec 2023 was $267,000, a 45.5% decline year-over-year.
  • Fresh Tracks Therapeutics, Inc. Share-based Payment Arrangement, Expense for the twelve months ending 31 Dec 2023 was $1,919,000, a 11% decline year-over-year.
  • Fresh Tracks Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2023 was $1,919,000, a 11% decline from 2022.
  • Fresh Tracks Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2022 was $2,156,000, a 4.73% decline from 2021.
  • Fresh Tracks Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2021 was $2,263,000, a 13.5% increase from 2020.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Change (%)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Change (%)

Fresh Tracks Therapeutics, Inc. Quarterly Share-based Payment Arrangement, Expense (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q4 2023 $1,919,000 $267,000 -$223,000 -46% 01 Oct 2023 31 Dec 2023 10-K 15 Mar 2024 2023 FY
Q3 2023 $2,142,000 $863,000 +$324,000 +60% 01 Jul 2023 30 Sep 2023 10-Q 13 Nov 2023 2023 Q3
Q2 2023 $1,818,000 $410,000 -$166,000 -29% 01 Apr 2023 30 Jun 2023 10-Q 11 Aug 2023 2023 Q2
Q1 2023 $1,984,000 $379,000 -$172,000 -31% 01 Jan 2023 31 Mar 2023 10-Q 10 May 2023 2023 Q1
Q4 2022 $2,156,000 $490,000 -$106,000 -18% 01 Oct 2022 31 Dec 2022 10-K 15 Mar 2024 2023 FY
Q3 2022 $2,262,000 $539,000 -$238,000 -31% 01 Jul 2022 30 Sep 2022 10-Q 13 Nov 2023 2023 Q3
Q2 2022 $2,500,000 $576,000 +$155,000 +37% 01 Apr 2022 30 Jun 2022 10-Q 11 Aug 2023 2023 Q2
Q1 2022 $2,345,000 $551,000 +$82,000 +17% 01 Jan 2022 31 Mar 2022 10-Q 10 May 2023 2023 Q1
Q4 2021 $2,263,000 $596,000 +$12,000 +2.1% 01 Oct 2021 31 Dec 2021 10-K 30 Mar 2023 2022 FY
Q3 2021 $2,251,000 $777,000 +$224,000 +41% 01 Jul 2021 30 Sep 2021 10-Q 14 Nov 2022 2022 Q3
Q2 2021 $2,027,000 $421,000 -$32,000 -7.1% 01 Apr 2021 30 Jun 2021 10-Q/A 01 Sep 2022 2022 Q2
Q1 2021 $2,059,000 $469,000 +$66,000 +16% 01 Jan 2021 31 Mar 2021 10-Q 12 May 2022 2022 Q1
Q4 2020 $1,993,000 $584,000 +$59,000 +11% 01 Oct 2020 31 Dec 2020 10-K 15 Mar 2022 2021 FY
Q3 2020 $1,934,000 $553,000 +$229,000 +71% 01 Jul 2020 30 Sep 2020 10-Q 09 Nov 2021 2021 Q3
Q2 2020 $1,705,000 $453,000 +$154,000 +52% 01 Apr 2020 30 Jun 2020 10-Q 12 Aug 2021 2021 Q2
Q1 2020 $1,551,000 $403,000 +$19,000 +4.9% 01 Jan 2020 31 Mar 2020 10-Q 13 May 2021 2021 Q1
Q4 2019 $1,532,000 $525,000 01 Oct 2019 31 Dec 2019 10-K 09 Mar 2021 2020 FY
Q3 2019 $324,000 +$173,000 +115% 01 Jul 2019 30 Sep 2019 10-Q 12 Nov 2020 2020 Q3
Q2 2019 $299,000 01 Apr 2019 30 Jun 2019 10-Q 12 Aug 2020 2020 Q2
Q1 2019 $384,000 01 Jan 2019 31 Mar 2019 10-Q 14 May 2020 2020 Q1
Q3 2018 $151,000 -$32,000 -17% 01 Jul 2018 30 Sep 2018 10-Q 14 Nov 2019 2019 Q3
Q4 2017 $800,000 $189,000 -$7,000 -3.6% 01 Oct 2017 31 Dec 2017 10-K 01 Mar 2019 2018 FY
Q3 2017 $807,000 $183,000 -$30,000 -14% 01 Jul 2017 30 Sep 2017 10-Q 24 Oct 2017 2017 Q3
Q2 2017 $837,000 $197,000 -$81,000 -29% 01 Apr 2017 30 Jun 2017 10-Q 08 Aug 2017 2017 Q2
Q1 2017 $918,000 $231,000 -$82,000 -26% 01 Jan 2017 31 Mar 2017 10-Q 15 May 2017 2017 Q1
Q4 2016 $1,000,000 $196,000 -$172,000 -47% 01 Oct 2016 31 Dec 2016 10-K 01 Mar 2019 2018 FY
Q3 2016 $1,172,000 $213,000 -$224,000 -51% 01 Jul 2016 30 Sep 2016 10-Q 24 Oct 2017 2017 Q3
Q2 2016 $1,396,000 $278,000 -$248,000 -47% 01 Apr 2016 30 Jun 2016 10-Q 08 Aug 2017 2017 Q2
Q1 2016 $1,644,000 $313,000 -$258,000 -45% 01 Jan 2016 31 Mar 2016 10-Q 15 May 2017 2017 Q1
Q4 2015 $1,902,000 $368,000 -$340,000 -48% 01 Oct 2015 31 Dec 2015 10-K 15 Mar 2018 2017 FY
Q3 2015 $2,242,000 $437,000 -$293,000 -40% 01 Jul 2015 30 Sep 2015 10-Q 04 Nov 2016 2016 Q3
Q2 2015 $2,535,000 $526,000 -$358,000 -40% 01 Apr 2015 30 Jun 2015 10-Q 09 Aug 2016 2016 Q2
Q1 2015 $2,893,000 $571,000 -$266,000 -32% 01 Jan 2015 31 Mar 2015 10-Q 09 May 2016 2016 Q1
Q4 2014 $3,159,000 $708,000 -$72,000 -9.2% 01 Oct 2014 31 Dec 2014 10-K 10 Mar 2017 2016 FY
Q3 2014 $3,231,000 $730,000 -$2,000 -0.27% 01 Jul 2014 30 Sep 2014 10-Q 30 Oct 2015 2015 Q3
Q2 2014 $3,233,000 $884,000 +$68,000 +8.3% 01 Apr 2014 30 Jun 2014 10-Q 30 Jul 2015 2015 Q2
Q1 2014 $3,165,000 $837,000 -$301,000 -26% 01 Jan 2014 31 Mar 2014 10-Q 08 May 2015 2015 Q1
Q4 2013 $3,466,000 $780,000 +$68,000 +9.6% 01 Oct 2013 31 Dec 2013 10-K 14 Mar 2016 2015 FY
Q3 2013 $3,398,000 $732,000 -$3,000 -0.41% 01 Jul 2013 30 Sep 2013 10-Q 03 Nov 2014 2014 Q3
Q2 2013 $3,401,000 $816,000 -$107,000 -12% 01 Apr 2013 30 Jun 2013 10-Q 01 Aug 2014 2014 Q2
Q1 2013 $3,508,000 $1,138,000 +$218,000 +24% 01 Jan 2013 31 Mar 2013 10-Q 02 May 2014 2014 Q1
Q4 2012 $3,290,000 $712,000 01 Oct 2012 31 Dec 2012 10-K 26 Feb 2015 2014 FY
Q3 2012 $735,000 -$12,000 -1.6% 01 Jul 2012 30 Sep 2012 10-Q 07 Nov 2013 2013 Q3
Q2 2012 $923,000 +$108,000 +13% 01 Apr 2012 30 Jun 2012 10-Q 01 Aug 2013 2013 Q2
Q1 2012 $920,000 01 Jan 2012 31 Mar 2012 10-Q 10 May 2013 2013 Q1
Q3 2011 $747,000 01 Jul 2011 30 Sep 2011 10-Q 07 Nov 2012 2012 Q3
Q2 2011 $815,000 01 Apr 2011 30 Jun 2011 10-Q 08 Aug 2012 2012 Q2

Fresh Tracks Therapeutics, Inc. Annual Share-based Payment Arrangement, Expense (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2023 $1,919,000 -$237,000 -11% 01 Jan 2023 31 Dec 2023 10-K 15 Mar 2024 2023 FY
2022 $2,156,000 -$107,000 -4.7% 01 Jan 2022 31 Dec 2022 10-K 15 Mar 2024 2023 FY
2021 $2,263,000 +$270,000 +14% 01 Jan 2021 31 Dec 2021 10-K 30 Mar 2023 2022 FY
2020 $1,993,000 +$461,000 +30% 01 Jan 2020 31 Dec 2020 10-K 15 Mar 2022 2021 FY
2019 $1,532,000 +$821,000 +115% 01 Jan 2019 31 Dec 2019 10-K 09 Mar 2021 2020 FY
2018 $711,000 -$89,000 -11% 01 Jan 2018 31 Dec 2018 10-K 18 Mar 2020 2019 FY
2017 $800,000 -$200,000 -20% 01 Jan 2017 31 Dec 2017 10-K 01 Mar 2019 2018 FY
2016 $1,000,000 -$902,000 -47% 01 Jan 2016 31 Dec 2016 10-K 01 Mar 2019 2018 FY
2015 $1,902,000 -$1,257,000 -40% 01 Jan 2015 31 Dec 2015 10-K 15 Mar 2018 2017 FY
2014 $3,159,000 -$307,000 -8.9% 01 Jan 2014 31 Dec 2014 10-K 10 Mar 2017 2016 FY
2013 $3,466,000 +$176,000 +5.4% 01 Jan 2013 31 Dec 2013 10-K 14 Mar 2016 2015 FY
2012 $3,290,000 +$184,000 +5.9% 01 Jan 2012 31 Dec 2012 10-K 26 Feb 2015 2014 FY
2011 $3,106,000 +$470,000 +18% 01 Jan 2011 31 Dec 2011 10-K 14 Feb 2014 2013 FY
2010 $2,636,000 01 Jan 2010 31 Dec 2010 10-K 15 Feb 2013 2012 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.